Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for November 22nd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 22:
BrainsWay Ltd. (BWAY - Free Report) : This commercial stage medical device company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.6% over the last 60 days.
Brainsway Ltd. Sponsored ADR Price and Consensus
Brainsway Ltd. Sponsored ADR price-consensus-chart | Brainsway Ltd. Sponsored ADR Quote
BrainsWay's shares gained 52.3% over the last three months compared with the S&P 500’s advance of 2.4%. The company possesses a Momentum Score of B.
Brainsway Ltd. Sponsored ADR Price
Brainsway Ltd. Sponsored ADR price | Brainsway Ltd. Sponsored ADR Quote
Rigel Pharmaceuticals, Inc. (RIGL - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.9% over the last 60 days.
Rigel Pharmaceuticals, Inc. Price and Consensus
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
Rigel Pharmaceuticals' shares gained 11.1% over the last one month compared with the S&P 500’s advance of 7.4%. The company possesses a Momentum Score of B.
Rigel Pharmaceuticals, Inc. Price
Rigel Pharmaceuticals, Inc. price | Rigel Pharmaceuticals, Inc. Quote
Dutch Bros Inc. (BROS - Free Report) : This drive-thru franchise company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Dutch Bros Inc. Price and Consensus
Dutch Bros Inc. price-consensus-chart | Dutch Bros Inc. Quote
Dutch Bros’ shares gained 16.7% over the last one month compared with the S&P 500’s advance of 7.4%. The company possesses a Momentum Score of A.
Dutch Bros Inc. Price
Dutch Bros Inc. price | Dutch Bros Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.